Skip to main navigation Skip to main content

Page translation not available

This page is not available in the language that has been selected and will appear in English.

Search

Contact us

07 3737 4500

PO Box 3787

South Brisbane QLD 4101
Donate

Our clinical trials and research

Research and clinical trials at Icon Cancer Foundation

At Icon Cancer Foundation (ICF), we fund vital clinical trials and research, improving cancer care and helping us find new, better and safer treatments for patients.

We support independent, investigator-initiated research led by researchers and clinicians across the Icon Cancer Centre network. Through these trials, we evaluate innovative new therapies in real-world settings.

Our research helps answer key questions:

  • Does this treatment work?

  • Is there a better treatment option than what’s already available?

  • Are there any side effects?

  • How can we improve the quality of life for patients?

By supporting ICF, you’re backing a team of researchers across Australia who work tirelessly for people with cancer.

Our goal is to build Australia’s leading private cancer research program — expanding access to innovative trials, closer to home, for as many patients as possible.

Active clinical trials supported by Icon Cancer Foundation

COMPRES

Evaluates use of compression therapy to help prevent and reduce oxaliplatin-induced peripheral neuropathy side effects.

Locations: Hobart
Diagnosis: Oxaliplatin-induced peripheral neuropathy

Learn more

PUMA

Randomised non-inferiority trial investigating patient-reported outcomes from partial breast irradiation (PBI) using external beam volumetric modulated arc therapy (VMAT).

Locations: Windsor Gardens, Wahroonga, Hobart, Toowoomba
Diagnosis: Breast cancer

Learn more

ROSEND

A randomised trial for the treatment of recalcitrant symptomatic rosacea using definitive volumetric modulated arc radiotherapy or standard dermatological treatment.

Locations: Gosford
Diagnosis: Rosacea

Learn more

TREMOR

Safety and effectiveness of frameless linac-based stereotactic radiosurgery on tremor in patients with essential tremor or Parkinson’s disease.

Locations: Epworth Richmond
Diagnosis: Neurological conditions

Learn more

Upcoming clinical trials

Additional trials are in development and will be available to patients in the future.

iROAR

Diagnosis: Osteoarthritis
Investigators: Associate Professor Peter Gorayski and Lydia Tamblyn

Past clinical trials

LIBERATE

Clinical registry of focal low dose rate brachytherapy in men with biopsy confirmed low-intermediate risk prostate cancer.

Status: Monitoring
Diagnosis: Prostate Cancer
Investigators: Dr Andrew See and Dr Eve Tiong

TRANSFORM

Stereotactic radiation therapy (SRT) for men with metastatic prostate cancer.

Status: Monitoring
Diagnosis: Prostate Cancer
Investigators: Dr Patrick Bowden